Evidence map›Paper›PMID 19266596›Full record

ReviewWorld journal of gastroenterology2009

Role of upper endoscopy in diagnosing opportunistic infections in human immunodeficiency virus-infected patients.

Ana Luiza Werneck-Silva, Ivete Bedin Prado

Open access · hybridAbstract readReview
In one paragraph

Review in World journal of gastroenterology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 52 citations in OpenAlex.

  1. Trial
  2. Pharmacokinetics of micafungin in HIV positive patients with confirmed esophageal candidiasis.European journal of drug metabolism and pharmacokinetics · 2012
    Trial
  3. GastrointestinalVideoGIE : an official video journal of the American Society for Gastrointestinal Endoscopy · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Frontiers in cellular and infection microbiology · 2021
    Review
  10. Article
  11. Observational
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Ana Luiza Werneck-SilvaCasa da AIDS-Infectious Disease Division, School of Medicine, University of São Paulo, Rua Frei Caneca 255, CEP:05403-000, São Paulo, Brazil. alwerneck@uol.com.br
Ivete Bedin Prado
Universidade de São Paulo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Highly active antiretroviral therapy (HAART) has dramatically decreased opportunistic infections (OIs) in human immunodeficiency virus (HIV)-infected patients. However, gastrointestinal disease continues to account for a high proportion of presenting symptoms in these patients. Gastrointestinal symptoms in treated patients who respond to therapy are more likely to the result of drug-induced complications than OI. Endoscopic evaluation of the gastrointestinal tract remains a cornerstone of diagnosis, especially in patients with advanced immunodeficiency, who are at risk for OI. The peripheral blood CD4 lymphocyte count helps to predict the risk of an OI, with the highest risk seen in HIV-infected patients with low CD4 count (< 200 cells/mm(3)). This review provides an update of the role of endoscopy in diagnosing OI in the upper gastrointestinal tract in HIV-infected patients in the era of HAART.

Indexed as

Antiretroviral Therapy, Highly ActiveBiopsyCandidiasisCD4 Lymphocyte CountCytomegalovirus InfectionsDeglutition DisordersEndoscopyEsophageal DiseasesGastrointestinal DiseasesHerpes SimplexHIV InfectionsHumansOpportunistic InfectionsPrevalenceStomach Diseases

Identifiers

PMID19266596
PMCPMC2655189
OpenAlexW2041294209

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.